Marja Van Sickle, PhD

University of British Columbia, Vancouver, Vancouver, BC, Canada 
"Marja Van Sickle"
Mean distance: 16.48 (cluster 40)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sharkey KA, Cristino L, Oland LD, et al. (2007) Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. The European Journal of Neuroscience. 25: 2773-82
Van Sickle MD, Duncan M, Kingsley PJ, et al. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science (New York, N.Y.). 310: 329-32
Sayani FA, Keenan CM, Van Sickle MD, et al. (2004) The expression and role of Fas ligand in intestinal inflammation. Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society. 16: 61-74
MacNaughton WK, Van Sickle MD, Keenan CM, et al. (2004) Distribution and function of the cannabinoid-1 receptor in the modulation of ion transport in the guinea pig ileum: relationship to capsaicin-sensitive nerves. American Journal of Physiology. Gastrointestinal and Liver Physiology. 286: G863-71
Van Sickle MD, Oland LD, Mackie K, et al. (2003) Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. American Journal of Physiology. Gastrointestinal and Liver Physiology. 285: G566-76
Boissé L, Van Sickle MD, Sharkey KA, et al. (2003) Compromised neuroimmune status in rats with experimental colitis. The Journal of Physiology. 548: 929-39
Inui A, Van Sickle M, Davison J, et al. (2002) Emesis, appetite, and endocannabinoids [5] (multiple letters) Gastroenterology. 123: 655-656
Van Sickle MD, Oland LD, Ho W, et al. (2001) Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology. 121: 767-74
See more...